Compared with the general population, individuals with LS and MMR gene germline mutations have a significantly higher lifetime risk of developing CRC, EC, and other malignancies such as gastric and ovarian cancers (Bonadona et al., 2011; Engel et al., 2012). The gene discussed is MRC1; the disease is colorectal carcinoma.